Literature DB >> 17464773

Inhibition of interleukin-12 production in mouse macrophages via suppression of nuclear factor-kappaB binding activity by Phyllostachys nigra var. henonis.

Seung Hyun Kim1, Tae Sung Kim, Sung Jun Kim, Chi Nam Seong, Oh Hyung Lee, Hyo Jung Lee, Jin Cheol Yoo.   

Abstract

Pharmacological inhibition of interleukin-12 (IL-12) production may be a therapeutic strategy for preventing development and progression of disease in experimental models of autoimmunity. The acetone fraction prepared from bamboo, Phyllostachys nigra var. henonis, potently inhibited the Lipo polysaccharide (LPS)-induced IL-12 production from RAW264.7 monocytic cell-line in a dose-dependent manner. The repressive effect mapped to a region in the IL-12 gene promoter containing a binding site for NF-kappaB. Furthermore, activation of macrophages by LPS resulted in markedly enhanced binding activity to the NF-kappaB site, which significantly decreased upon addition of the acetone fraction of Phyllostachys nigra var. henonis. This indicated that the acetone fraction inhibited IL-12 production in LPS-activated macrophages via inhibition of NF-kappaB binding activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17464773     DOI: 10.1080/08923970701283476

Source DB:  PubMed          Journal:  Immunopharmacol Immunotoxicol        ISSN: 0892-3973            Impact factor:   2.730


  3 in total

1.  Potential Medicinal Application and Toxicity Evaluation of Extracts from Bamboo Plants.

Authors:  Jun Panee
Journal:  J Med Plant Res       Date:  2015-06-17

2.  Phyllostachys edulis compounds inhibit palmitic acid-induced monocyte chemoattractant protein 1 (MCP-1) production.

Authors:  Jason K Higa; Zhibin Liang; Philip G Williams; Jun Panee
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

3.  Bambusae caulis in Liquamen Suppresses the Expression of Thymus and Activation-Regulated Chemokine and Macrophage-Derived Chemokine in Human Keratinocytes due to Antioxidant Effect.

Authors:  Xu-Feng Qi; Dong-Heui Kim; Yang-Suk Yoon; Soon-Bong Song; Yung-Chien Teng; Dong-Qing Cai; Kyu-Jae Lee
Journal:  Evid Based Complement Alternat Med       Date:  2011-07-06       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.